Sun Pharma expands tie-up with Cassiopea for acne cream to six countries
As per the tie-up, the company will receive from Cassiopea the exclusive right to develop and commercialise WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia, Sun Pharma said in a statement.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Acne | Australia Health | Biotechnology | Brazil Health | Japan Health | Mexico Health | New Zealand Health | Pharmaceuticals | Russia Health